Children With Cancer Have Greater Risk of Severe COVID-19 Outcomes
About 20% of pediatric cancer patients who developed COVID-19 had severe or critical disease.
Hematologic Cancers
Lymphoma Patients Show Continued Cognitive Decline After Chemotherapy
Lymphoma patients displayed cognitive decline 6 months after chemotherapy, both by objective assessment and self-report.
Responses to COVID-19 Vaccines in Cancer Patients: Impact of Tumor and Treatment Type
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
Responses to COVID-19 Vaccines Vary in Patients With Hematologic Malignancies
Responses varied according to patients’ cancer type, the anticancer treatment they received, and which vaccine was used.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
Study Finds Association Between Hypertension and Ibrutinib Treatment
Researchers defined the association between blood pressure and ibrutinib compared with chemoimmunotherapy in patients with B cell malignancies.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
Additional Tablet Strengths of Xpovio Now Available
The additional strengths are intended to increase patient compliance and reduce pill burden.
- Loading...
Loading...
Loading... 
Loading...